Effect of niacin on atherosclerotic cardiovascular disease

Morgan, 1996, Treatment effect of Niaspan, a controlled-release niacin, in patients with hypercholesterolemia, J Cardiovasc Pharmacol, 1, 195, 10.1177/107424849600100302 Guyton, 1998, Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia, Am J Cardiol, 82, 737, 10.1016/S0002-9149(98)00448-2 1975, Clofibrate and niacin in coronary heart disease, JAMA, 231, 360, 10.1001/jama.1975.03240160024021 Canner, 1986, Fifteen-year mortality in Coronary Drug Project patients, J Am Coll Cardiol, 8, 1245, 10.1016/S0735-1097(86)80293-5 Carlson, 1988, Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid, Acta Med Scand, 223, 405, 10.1111/j.0954-6820.1988.tb15891.x Manninen, 1989, Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study, Am J Cardiol, 63, 42H, 10.1016/0002-9149(89)90115-X 1978, A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate, Br Heart J, 40, 1069, 10.1136/hrt.40.10.1069 Blankenhorn, 1987, Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA, 257, 3233, 10.1001/jama.1987.03390230069027 Cashin-Hemphill, 1990, Beneficial effects of colestipol-niacin on coronary atherosclerosis, JAMA, 264, 3013, 10.1001/jama.1990.03450230049028 Brown, 1990, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B, N Engl J Med, 323, 1289, 10.1056/NEJM199011083231901 Kane, 1990, Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens, JAMA, 264, 3007, 10.1001/jama.1990.03450230043027 Sacks, 1994, Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolemic patients, Lancet, 344, 1182, 10.1016/S0140-6736(94)90506-1